Insider Selling: Penumbra Inc (PEN) Insider Sells 47,136 Shares of Stock

Penumbra Inc (NYSE:PEN) insider Arani Bose sold 47,136 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $105.15, for a total transaction of $4,956,350.40. Following the completion of the transaction, the insider now directly owns 700,815 shares of the company’s stock, valued at approximately $73,690,697.25. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Arani Bose also recently made the following trade(s):

  • On Tuesday, November 28th, Arani Bose sold 10,927 shares of Penumbra stock. The shares were sold at an average price of $103.96, for a total value of $1,135,970.92.
  • On Wednesday, November 22nd, Arani Bose sold 6,248 shares of Penumbra stock. The shares were sold at an average price of $106.10, for a total value of $662,912.80.
  • On Friday, November 17th, Arani Bose sold 8,133 shares of Penumbra stock. The shares were sold at an average price of $103.50, for a total value of $841,765.50.
  • On Wednesday, November 15th, Arani Bose sold 16,452 shares of Penumbra stock. The shares were sold at an average price of $105.89, for a total value of $1,742,102.28.

Penumbra Inc (NYSE:PEN) traded down $0.35 during trading hours on Wednesday, hitting $99.50. 180,000 shares of the stock were exchanged, compared to its average volume of 191,841. Penumbra Inc has a 52 week low of $61.40 and a 52 week high of $116.35.

Penumbra (NYSE:PEN) last posted its quarterly earnings data on Tuesday, November 7th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.07. Penumbra had a negative net margin of 2.19% and a negative return on equity of 1.95%. The firm had revenue of $83.90 million during the quarter, compared to analysts’ expectations of $79.17 million. During the same quarter in the previous year, the company posted ($0.04) EPS. Penumbra’s revenue was up 24.9% on a year-over-year basis. sell-side analysts forecast that Penumbra Inc will post -0.15 EPS for the current fiscal year.

A number of equities research analysts recently weighed in on the company. BidaskClub raised Penumbra from a “hold” rating to a “buy” rating in a research report on Saturday, August 12th. Zacks Investment Research downgraded Penumbra from a “hold” rating to a “sell” rating in a research report on Saturday, August 12th. Canaccord Genuity restated a “buy” rating and set a $100.00 price target (up previously from $94.00) on shares of Penumbra in a research note on Wednesday, August 9th. Finally, BMO Capital Markets raised their price target on shares of Penumbra from $96.00 to $117.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 8th.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PEN. Suntrust Banks Inc. grew its holdings in shares of Penumbra by 2.6% in the 2nd quarter. Suntrust Banks Inc. now owns 4,023 shares of the company’s stock valued at $353,000 after buying an additional 101 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Penumbra by 10.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,159 shares of the company’s stock worth $102,000 after purchasing an additional 114 shares during the period. Principal Financial Group Inc. boosted its stake in Penumbra by 0.9% in the 1st quarter. Principal Financial Group Inc. now owns 13,031 shares of the company’s stock worth $1,087,000 after purchasing an additional 121 shares during the period. Ameritas Investment Partners Inc. boosted its stake in Penumbra by 10.8% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,573 shares of the company’s stock worth $226,000 after purchasing an additional 250 shares during the period. Finally, Stifel Financial Corp boosted its stake in Penumbra by 2.1% in the 2nd quarter. Stifel Financial Corp now owns 16,226 shares of the company’s stock worth $1,421,000 after purchasing an additional 340 shares during the period. 71.71% of the stock is owned by hedge funds and other institutional investors.

WARNING: This piece was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/12/06/penumbra-inc-pen-insider-sells-4956350-40-in-stock.html.

About Penumbra

Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Insider Buying and Selling by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply